A detailed business plan was prepared for a biometric smartcard venture. The smartcard was designed to carry medical data, reduce healthcare fraud, and prevent treatment errors due to patient misidentification.  The business plan included a detailed analysis of the biometric security industry and healthcare market.  A comprehensive competitive analysis was performed, and several strategic approaches were evaluated to optimize partnership-driven, market penetration.  Virtual prototypes of a biometric smartcard and its intelligent reader device were created, as well as schemes for enterprise integration.  A team was assembled with the necessary skills, expertise, and experience, and a world-renowned biometric security expert was recruited for the advisory board.  Detailed financial analyses were performed to determine revenue and cash flow projections and staged funding requirements.  As part of the business strategy development, over 23 major healthcare insurance carriers were interviewed for their feedback on this product concept.  The result was a detailed sales and marketing plan designed to address customer concerns, pricing, and adoption hurdles.  The business plan was presented to three panels of venture capital firms.

Herbal Bandage

A marketing plan was prepared to determined how a China-based firm can distribute and sell its herbal bandage in the US market.  The bandage contains a derivative of the Chinese herb Yunnan Baiyou, which can stop bleeding instantly.  Though a survey of active adults, it was determined that consumers would be willing to pay a premium for a bandage that would stop bleeding instantly and were not brand loyal. The market demand for this herbal bandage was estimated at 100 million units in sales annually, representing $274 million dollars per year.  To successfully penetrate the US market, its was recommended that the firm target active adults, develop partnership agreements with supermarket and pharmacy distribution channels, price the bandage slightly below other premium bandages in the market, and develop a name that signals its primary benefit - stop bleeding instantly.

Biotech Tools

A detailed competitor and market assessment was performed for a well-known equipment vendor in the biotech industry.  As the dominant leader in its market, the firm needed a growth strategy to satisfy current investors.  Its product line had matured with few new innovations on the horizon.  After evaluating different customer segments in this market, unique strategies were developed for each customer segment.  The expected return on investment was determined for each proposed segment strategy.  Each segment strategy was then examined, analyzing the expected responses from key competitors using game theory analysis.  From this competitive analysis and the expected return on investments, final recommendations were developed to enhance the firm's brand image, to realign product pricing, to maximize revenues, to target specific product improvements that meet customer needs, and to deepen the relationship with the firm's customers using an e-commerce tool.